Leap Therapeutics earnings were -$64.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest LPTX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$18.2M, down 10.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, LPTX reported annual earnings of -$81.4M, with 49.1% growth. The next LPTX earnings date is Mar 17, 2025.
What were Leap Therapeutics's earnings last quarter?
On LPTX's earnings call on Invalid Date, Leap Therapeutics (NASDAQ: LPTX) reported Q3 2024 earnings per share (EPS) of -$0.44, up 13.73% year over year. Total LPTX earnings for the quarter were -$18.18 million. In the same quarter last year, Leap Therapeutics's earnings per share (EPS) was -$0.51.
The next LPTX earnings call is Invalid Date. Add LPTX to your watchlist to be reminded of Leap Therapeutics's next earnings date.
What was LPTX's earnings growth in the past year?
As of Leap Therapeutics's earnings date in Invalid Date, Leap Therapeutics's earnings has grown year over year. LPTX earnings in the past year totalled -$64.82 million.
Is Leap Therapeutics profitable or losing money?
As of the last Leap Therapeutics earnings report, Leap Therapeutics is currently losing money. Leap Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$64.59 million, a 20.31% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.